GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹138 Cr | ₹1,705 Cr | ₹-1,757 Cr | ₹1,208 Cr | ₹-1,003 Cr |
What is the latest Cash Flow from Investing Activities ratio of GLAND PHARMA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹138 Cr |
| Mar2025 | ₹1,705 Cr |
| Mar2024 | ₹-1,757 Cr |
| Mar2023 | ₹1,208 Cr |
| Mar2022 | ₹-1,003 Cr |
How is Cash Flow from Investing Activities of GLAND PHARMA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹138 Cr | -91.92 | |
| Mar2025 | ₹1,705 Cr | Positive | |
| Mar2024 | ₹-1,757 Cr | Negative | |
| Mar2023 | ₹1,208 Cr | Positive | |
| Mar2022 | ₹-1,003 Cr | - | |
Compare Cash Flow from Investing Activities of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹50,955.3 Cr | 2.4% | 1.8% | 57.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -2.3% | -5.9% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -1.7% | -1.1% | 60.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -2.1% | -5.1% | 32.2% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | -2.2% | -4% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 1.8% | 7.6% | -4.3% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 2.4% |
1.8% |
57.9% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses